Akynzeo 300-0.5 MG capsules
Ended Awarded Last action
- Contract number
- SPE2DR26FV921
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,513
Award facts
- Contract value 100% obligated
- $11,512.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,512.83 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of AKYNZEO 300-0.5 mg capsules, with completion scheduled for February 2, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which provides a comprehensive vehicle for global pharmaceutical and medical supply delivery to support military healthcare programs.
AKYNZEO is an antiemetic medication commonly used to prevent chemotherapy-induced nausea and vomiting. This delivery order represents a routine pharmaceutical procurement through DLA's established supply chain infrastructure, leveraging the broader IDC that enables efficient fulfillment of critical medical commodities across multiple therapeutic domains for Defense Health Agency facilities, military treatment centers, and other federal healthcare systems. AmerisourceBergen's extensive portfolio of federal contracts and proven capability to compete on a full and open basis positions the company as a key vendor within the military's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FV921?
SPE2DR26FV921 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FV921 worth?
The government has obligated $11,513 on SPE2DR26FV921.
Is contract SPE2DR26FV921 an order under another contract?
Yes. SPE2DR26FV921 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV921 competed?
The extent of competition for SPE2DR26FV921 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award